Spectrum of Histomorphologic Findings in Liver in Patients with SLE: A Review
Author(s) -
Shrruti Grover,
Archana Rastogi,
Jyotsna Singh,
Apurba Rajbongshi,
Chhagan Bihari
Publication year - 2014
Publication title -
hepatitis research and treatment
Language(s) - English
Resource type - Journals
eISSN - 2090-1372
pISSN - 2090-1364
DOI - 10.1155/2014/562979
Subject(s) - medicine , nodular regenerative hyperplasia , histopathology , pathology , etiology , autoimmune hepatitis , portal hypertension , fatty liver , rheumatoid arthritis , systemic lupus erythematosus , hepatitis , disease , immunology , cirrhosis
Collagen vascular diseases (CVDs) like systemic lupus erythematosus (SLE), rheumatoid arthritis, Sjogren syndrome (SS), and scleroderma are immunologically mediated disorders that typically have multisystem involvement. Although clinically significant liver involvement is rare, liver enzyme abnormalities are common in these patients. The reported prevalence of hepatic involvement in SLE, histopathologic findings, and its significance is very variable in the existing literature. It is important to be familiar with the causes of hepatic involvement in SLE along with histomorphological features which aid in distinguishing hepatitis of SLE from other hepatic causes as they would alter the patient management and disease course. Histopathology of liver in SLE shows a wide morphological spectrum commonly due to a coexisting pathology. Drug induced hepatitis, viral etiology, and autoimmune overlap should be excluded before attributing the changes to SLE itself. Common histopathologic findings in SLE include fatty liver, portal inflammation, and vascular changes like hemangioma, congestion, nodular regenerative hyperplasia, arteritis, and abnormal vessels in portal tracts.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom